Literature DB >> 26100679

TRIF adaptor signaling is important in abdominal aortic aneurysm formation.

Emina Vorkapic1, Anna M Lundberg2, Mikko I Mäyränpää3, Per Eriksson4, Dick Wågsäter5.   

Abstract

OBJECTIVE: Abdominal aortic aneurysm (AAA) is characterized by inflammation, loss of smooth muscle cells (SMCs), and degradation of the extracellular matrix in the vessel wall. Innate immune receptors such as Toll-like receptors (TLRs) were recently shown to regulate immunological processes leading to the formation and progression of atherosclerotic plaques as well as to other cardiovascular pathologies. Our aim was to investigate whether blockage of TLR signaling, under the control of TIR domain-containing adaptor protein including IFN-β (TRIF), could inhibit the inflammatory response and AAA development in mice.
RESULTS: In human AAA, an increased TLR3 and TLR4 expression in association with macrophages and T lymphocytes was demonstrated with immunohistochemical analysis. Angiotensin (Ang) II-induced aneurysm formation was significantly reduced by 30% in ApoE(-/-)Trif(-/-) mice compared to ApoE(-/-) mice. Morphologically, AngII-infused ApoE(-/-)Trif(-/-) mice had a more intact cellular and extracellular matrix while ApoE(-/-) mice infused with AngII displayed an increased medial thickness associated with aortic dissection, thrombus formation, and a more disorganized vessel wall. Gene expression analysis of the abdominal aorta revealed a profound decrease of the inflammatory genes CD68 (P < 0.05), CD11b (P < 0.05), and TNF-α (P < 0.05) and the protease gene MMP-12 (P < 0.01) in ApoE(-/-)Trif(-/-) mice compared to ApoE(-/-) mice infused with AngII.
CONCLUSION: Our results suggest that signaling through TRIF is important for the inflammatory response of AngII-induced AAA and that blockage of the TRIF pathway reduces vascular inflammation and protects against AAA formation.
Copyright © 2015 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Angiontensin II; Inflammation; Toll-like receptor; Vascular disease

Mesh:

Substances:

Year:  2015        PMID: 26100679     DOI: 10.1016/j.atherosclerosis.2015.06.014

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

1.  Andrographolide Ameliorates Abdominal Aortic Aneurysm Progression by Inhibiting Inflammatory Cell Infiltration through Downregulation of Cytokine and Integrin Expression.

Authors:  Jun Ren; Zhenjie Liu; Qiwei Wang; Jasmine Giles; Jason Greenberg; Nader Sheibani; K Craig Kent; Bo Liu
Journal:  J Pharmacol Exp Ther       Date:  2015-10-19       Impact factor: 4.030

Review 2.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

3.  Insight into the expression of toll-like receptors 2 and 4 in patients with abdominal aortic aneurysm.

Authors:  Agnieszka Jabłońska; Christoph Neumayer; Michael Bolliger; Christopher Burghuber; Markus Klinger; Svitlana Demyanets; Josif Nanobachvili; Ihor Huk
Journal:  Mol Biol Rep       Date:  2020-03-07       Impact factor: 2.316

4.  ADAMTS-1 in abdominal aortic aneurysm.

Authors:  Emina Vorkapic; Maggie Folkesson; Kerstin Magnell; Mohammad Bohlooly-Y; Toste Länne; Dick Wågsäter
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

5.  An in vitro method to keep human aortic tissue sections functionally and structurally intact.

Authors:  Jorn P Meekel; Menno E Groeneveld; Natalija Bogunovic; Niels Keekstra; René J P Musters; Behrouz Zandieh-Doulabi; Gerard Pals; Dimitra Micha; Hans W M Niessen; Arno M Wiersema; Jur K Kievit; Arjan W J Hoksbergen; Willem Wisselink; Jan D Blankensteijn; Kak K Yeung
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

6.  Serum levels of matrix metalloproteinase 9 and toll-like receptor 4 in acute aortic dissection: a case-control study.

Authors:  Tan Li; Jing-Jing Jing; Jun Yang; Li-Ping Sun; Yue-Hua Gong; Shi-Jie Xin; Yuan Yuan
Journal:  BMC Cardiovasc Disord       Date:  2018-11-29       Impact factor: 2.298

7.  TRIF Regulates BIC/miR-155 via the ERK Signaling Pathway to Control the ox-LDL-Induced Macrophage Inflammatory Response.

Authors:  Yaxi Wu; Jinshan Ye; Ruiwei Guo; Xing Liang; Lixia Yang
Journal:  J Immunol Res       Date:  2018-06-07       Impact factor: 4.818

Review 8.  MyD88: At the heart of inflammatory signaling and cardiovascular disease.

Authors:  Abraham L Bayer; Pilar Alcaide
Journal:  J Mol Cell Cardiol       Date:  2021-08-08       Impact factor: 5.000

Review 9.  Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders.

Authors:  Rezan Ashayeri Ahmadabad; Zahra Mirzaasgari; Ali Gorji; Maryam Khaleghi Ghadiri
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  Inhibition of miR-155 attenuates abdominal aortic aneurysm in mice by regulating macrophage-mediated inflammation.

Authors:  Zhidong Zhang; Kai Liang; Gangqiang Zou; Xiaosan Chen; Shuaitao Shi; Guoquan Wang; Kewei Zhang; Kun Li; Shuiting Zhai
Journal:  Biosci Rep       Date:  2018-05-08       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.